Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
To the Editor: Drs Ioannidis and Lau1 recommend publication guidelines to promote more complete safety reports. Their conclusions are based on investigator-defined indicators of reporting completeness. While the qualitative indicators address important aspects of safety reporting, their quantitative measure of data completeness (extent of article space devoted to safety) seems contrived.
Neidig JL, Koletar SL. Safety Reporting in Clinical Trials. JAMA. 2001;285(16):2076-2078. doi:10.1001/jama.285.16.2076